During the past decade, Clinstile, S.A. de C.V. conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 11 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 10 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinstile, S.A. de C.V." #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Boehringer Ingelheim" with 5 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Galapagos NV" with 3 trials sponsored and "R-Pharm International, LLC" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinstile, S.A. de C.V." #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Quintiles, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinstile, S.A. de C.V." are "Rheumatoid Arthritis" (6 trials), "COVID-19" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Clinstile, S.A. de C.V." in a lesser frequency.

Most popular intervention types in "Clinstile, S.A. de C.V." are "Drug" (23 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Ocrelizumab" (4 trials), "BI 685509" (2 trials), "Baricitinib" (2 trials) and "Fenebrutinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinstile, S.A. de C.V." are 24 trials for "All" genders.

Currently, there are NaN active trials in "Clinstile, S.A. de C.V.". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Clinstile, S.A. de C.V., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinstile, S.A. de C.V., 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".